3-AMINO-4,6-DIFLUORO-1H-INDAZOLE, 95%, 250mg

3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile, 95%, 50mg

2,2-Diethoxy-N-(4-(hexyloxy)benzyl)ethanamine, 97%, 250mg

2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)propanoate, 98%, 1g

XPhos Pd G3, ?98.0%, 10g

3-methylimidazo[1,5-a]pyridine-1-carboxylic acid, >95%, 1g

Isobutylene Sulfide>98.0%(GC)25mL

tert-Butyl 7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate, 95.0%, 100g

2,3,5-Triphenyltetrazolium chloride, 98.0%, 25g

5-Methyl-4,5,6,7-tetrahydro-2,1-benzisoxazol-3-amine, 95.0%, 1g

(S)-1-Boc-2-Methyl-[1,4]diazepane, 95.0%, 250mg

(R)-1-[3,5-Bis(trifluoromethyl)phenyl], ethanol, min. 99%, 25 g, glass packaging

(S)-4-Isopropyl-2-oxazolidinone, 98.0%, 1g